| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |